Darinaparsin (ZIO-101) enhances the sensitivity of small-cell lung cancer to PARP inhibitors (vol 0, pg 1, 2022)

doi:10.1038/s41401-022-01019-w

	Darinaparsin (ZIO-101) enhances the sensitivity of small-cell lung cancer to PARP inhibitors (vol 0, pg 1, 2022)
	Cao, Guo-zhen 3,4,5; Ma, Li-ying 3,4,5; Zhang, Zong-hui 1,3; Wang, Xiao-lin 4; Hua, Jing-han 3,4,5; Zhang, Jia-hui 3,4,5; Lv, Yang 3,4,5; Zhang, Shao-bo 1,3; Ou, Jian 2; Lin, Wen-chu 3,4,5
刊名	ACTA PHARMACOLOGICA SINICA
	2022-11-13
ISSN号	1671-4083
DOI	10.1038/s41401-022-01019-w
通讯作者	Lin, Wen-chu(wenchu@hmfl.ac.cn)
WOS研究方向	Chemistry ; Pharmacology & Pharmacy
语种	英语
出版者	NATURE PUBL GROUP
WOS记录号	WOS:000882742800001
内容类型	期刊论文
源URL	[http://ir.hfcas.ac.cn:8080/handle/334002/130383]
专题	中国科学院合肥物质科学研究院
通讯作者	Lin, Wen-chu
作者单位	1.Anhui Med Univ, Sch Basic Med, Hefei 230032, Peoples R China 2.Nanjing Med Univ, Suzhou Municipal Hosp, Ctr Reprod & Genet, Affiliated Suzhou Hosp, Suzhou 215002, Peoples R China 3.Chinese Acad Sci, High Magnet Field Lab, Hefei Inst Phys Sci, Hefei 230031, Peoples R China 4.Univ Sci & Technol China, Hefei 230036, Peoples R China 5.Chinese Acad Sci, Key Lab High Magnet Field &Beam Phys Biol, Hefei Inst Phys Sci, Hefei 230031, Peoples R China
推荐引用方式 GB/T 7714	Cao, Guo-zhen,Ma, Li-ying,Zhang, Zong-hui,et al. Darinaparsin (ZIO-101) enhances the sensitivity of small-cell lung cancer to PARP inhibitors (vol 0, pg 1, 2022)[J]. ACTA PHARMACOLOGICA SINICA,2022.
APA	Cao, Guo-zhen.,Ma, Li-ying.,Zhang, Zong-hui.,Wang, Xiao-lin.,Hua, Jing-han.,...&Lin, Wen-chu.(2022).Darinaparsin (ZIO-101) enhances the sensitivity of small-cell lung cancer to PARP inhibitors (vol 0, pg 1, 2022).ACTA PHARMACOLOGICA SINICA.
MLA	Cao, Guo-zhen,et al."Darinaparsin (ZIO-101) enhances the sensitivity of small-cell lung cancer to PARP inhibitors (vol 0, pg 1, 2022)".ACTA PHARMACOLOGICA SINICA (2022).